Drug Shortage Report for ACT RANITIDINE

Last updated on 2019-08-06 History
Report ID 86927
Drug Identification Number 02248570
Brand name ACT RANITIDINE
Common or Proper name RANITIDINE
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-18
Estimated end date 2019-07-30
Actual end date 2019-07-30
Shortage status Resolved
Updated date 2019-08-06
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-08-06 French Compare
v6 2019-08-06 English Compare
v5 2019-06-27 French Compare
v4 2019-06-27 English Compare
v3 2019-06-19 English Compare
v2 2019-06-18 French Compare
v1 2019-06-18 English Compare